|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| C07K 14/705 | |||
| C12N 5/10 | |||
| C07K 16/22 |
| (11) | Patento numeris | 2329837 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10009325.1 |
| Europos patento paraiškos padavimo data | 2006-11-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-06-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-04-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 739462 P | 2005-11-23 | US | |
| 844855 P | 2006-09-15 | US | |
| 783322 P | 2006-03-17 | US |
| (72) |
Knopf, John, US
Jasbir, Seehra, US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | Anti-activin A or B antibodies and use thereof for promoting bone growth |
| Anti-activin A or B antibodies and use thereof for promoting bone growth |